ESCONDIDO, Calif., March 23, 2020 /PRNewswire/ -- MARIJUANA COMPANY OF AMERICA INC. ("MCOA" or the "Company") (OTCQB: MCOA), an innovative hemp and cannabis corporation, is pleased to announce that the subsidiary, hempSMART™, will offer products to consumers at a substantial savings.
In today's climate of concern about immune system health, Paula Vetter FNP, Chairman of hempSMART's Medical Advisory Board, pointed out that "maintaining a healthy immune system requires a multi-faceted approach. Along with common sense measures like social distancing and hand washing, we can enable our immune system to function optimally by specifically supporting our Endocannabinoid System with a quality CBD product."
The Journal of Cannabis & Cannabinoid Research (Sept 2019) recently published findings that demonstrate that the immune system is modulated by the Endocannabinoid System (ECS). This system, which is present in humans and all other mammals, acts as the "orchestra conductor" of the body.
The ECS has three major functions:
- to balance & regulate immune response & inflammation
- to balance & regulate brain chemistry (neurotransmitters)
- to balance & regulate hormone levels (sex hormones, adrenal hormones, thyroid hormones)
Vetter emphasized that "CBD is very popular, but many available products are not therapeutic. All CBD is NOT created equal. Our hempSMART CBD drops are organically grown, contain the full spectrum of cannabinoids, terpenes, and flavonoids (with selective removal of only THC). That means no 'high' or risk of failing a drug test. Most importantly, the purity, potency, and integrity of the product is verified by an independent certified laboratory. Comprehensive Certificates of Analysis, for every batch of every product, guarantee that hempSMART is a brand that you can TRUST."
"NO CBD product specifically treats disease," said Vetter. "A high quality, bioavailable, full spectrum CBD will powerfully support the ECS to carry out its important functions. Supporting the wisdom of the human body is the BEST defense we have against any health challenge."
Trevor Meuhfelder, COO of hempSMART™ states, "With the limitation of services and precautionary measures being taken currently, MCOA believes that this is an opportunity to ramp up our sales of CBD products as immune system health is critical. Our products are specifically designed to help maintain a healthy endocannabinoid system which directly contributes to the functionality of the immune system."
Global Sales and Marketing Director, Gloria Lynch, "We are now providing an online promotion for hempSMART DROPS, 250 mg tinctures which we are offering at $30.00 (regularly $45.00). We have recently seen an increase demand for our hempSMART Drops and we are happy to provide consumers with our superior products."
Go to https://shop.hempsmart.com/#/shop/detail/FST250-LEMN/from/1271. "I am in complete agreement with Paula Vetter that in this stressful time anything we can do to strengthen our immune system will be very beneficial. It is important to support our natural ability to manage stress and to regulate & optimize our immune response to any challenge.
Everyone needs to stay safe, and follow the World Health Organization (WHO) recommendations of socially distancing ourselves and working remotely if possible.
Take the time to reconnect with loved ones, care for each other and support each other," Jesus Quintero, MCOA, CEO.
The Company's CEO went on to state, "MCOA is also aggressively looking and performing due diligence on various possible acquisition targets in the cannabis sector. This recent dramatic market correction in our sector and in the overall economy has introduced several opportunities to buy strategic distressed assets in the cannabis sector. As a public company, we are looking to acquire strategic assets and companies at deep discounts to benefit us and increase reported revenue. "
Please visit www.hempsmart.com for details about our product-line.
About Marijuana Company of America Inc.
MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name hempSMART™, which targets general health and well-being; (2) an affiliate marketing and retail sales program to promote and sell its legal hemp-based consumer products containing CBD; (3) joint ventures and acquisitions of business entities engaged in the growth and sale of hemp and cannabis products in jurisdictions where cultivation is legal; and (4) the expansion of its business into ancillary areas as market opportunities in this segment mature and develop.
Legal Status of Cannabis
While legalized in California for recreational and medicinal use, cannabis remains a Schedule 1 drug under the Controlled Substances Act (21 U.S.C. § 811) and illegal under the federal law.
This news release contains "forward-looking statements," which are not purely historical and may include any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs, and results of new business opportunities and words such as "anticipate," "seek," "intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q, and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
For more information, please visit the Company's websites at:
SOURCE Marijuana Company of America, Inc.